217 related articles for article (PubMed ID: 17628858)
1. Antigen co-encapsulated with adjuvants efficiently drive protective T cell immunity.
Heit A; Schmitz F; Haas T; Busch DH; Wagner H
Eur J Immunol; 2007 Aug; 37(8):2063-74. PubMed ID: 17628858
[TBL] [Abstract][Full Text] [Related]
2. The immunogenicity of CpG-antigen conjugates.
Wagner H
Adv Drug Deliv Rev; 2009 Mar; 61(3):243-7. PubMed ID: 19174176
[TBL] [Abstract][Full Text] [Related]
3. Vaccine protocols for enhanced immunogenicity of exogenous antigens.
Heit A; Busch DH; Wagner H; Schmitz F
Int J Med Microbiol; 2008 Jan; 298(1-2):27-32. PubMed ID: 17888726
[TBL] [Abstract][Full Text] [Related]
4. Targeting split vaccines to the endosome improves vaccination.
Wagner H; Heit A; Schmitz F; Bauer S
Curr Opin Biotechnol; 2004 Dec; 15(6):538-42. PubMed ID: 15560980
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable nanoparticles containing TLR3 or TLR9 agonists together with antigen enhance MHC-restricted presentation of the antigen.
Lee YR; Lee YH; Im SA; Yang IH; Ahn GW; Kim K; Lee CK
Arch Pharm Res; 2010 Nov; 33(11):1859-66. PubMed ID: 21116790
[TBL] [Abstract][Full Text] [Related]
6. TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses.
Schlosser E; Mueller M; Fischer S; Basta S; Busch DH; Gander B; Groettrup M
Vaccine; 2008 Mar; 26(13):1626-37. PubMed ID: 18295941
[TBL] [Abstract][Full Text] [Related]
7. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles.
Shen H; Ackerman AL; Cody V; Giodini A; Hinson ER; Cresswell P; Edelson RL; Saltzman WM; Hanlon DJ
Immunology; 2006 Jan; 117(1):78-88. PubMed ID: 16423043
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity.
Huleatt JW; Jacobs AR; Tang J; Desai P; Kopp EB; Huang Y; Song L; Nakaar V; Powell TJ
Vaccine; 2007 Jan; 25(4):763-75. PubMed ID: 16968658
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of CpG oligonucleotide ligand into protein-loaded particle vaccines promotes antigen-specific CD8 T-cell immunity.
Standley SM; Mende I; Goh SL; Kwon YJ; Beaudette TT; Engleman EG; Fréchet JM
Bioconjug Chem; 2007; 18(1):77-83. PubMed ID: 17226959
[TBL] [Abstract][Full Text] [Related]
10. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
[TBL] [Abstract][Full Text] [Related]
11. Human plasmacytoid dendritic cells phagocytose, process, and present exogenous particulate antigen.
Tel J; Lambeck AJ; Cruz LJ; Tacken PJ; de Vries IJ; Figdor CG
J Immunol; 2010 Apr; 184(8):4276-83. PubMed ID: 20304825
[TBL] [Abstract][Full Text] [Related]
12. Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells.
Denis-Mize KS; Dupuis M; MacKichan ML; Singh M; Doe B; O'Hagan D; Ulmer JB; Donnelly JJ; McDonald DM; Ott G
Gene Ther; 2000 Dec; 7(24):2105-12. PubMed ID: 11223992
[TBL] [Abstract][Full Text] [Related]
13. Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo.
Sheng KC; Kalkanidis M; Pouniotis DS; Esparon S; Tang CK; Apostolopoulos V; Pietersz GA
Eur J Immunol; 2008 Feb; 38(2):424-36. PubMed ID: 18200633
[TBL] [Abstract][Full Text] [Related]
14. Poly(I:C) coated PLGA microparticles induce dendritic cell maturation.
Wischke C; Zimmermann J; Wessinger B; Schendler A; Borchert HH; Peters JH; Nesselhut T; Lorenzen DR
Int J Pharm; 2009 Jan; 365(1-2):61-8. PubMed ID: 18812217
[TBL] [Abstract][Full Text] [Related]
15. Encapsulation of antigen in poly(D,L-lactide-co-glycolide) microspheres protects from harmful effects of γ-irradiation as assessed in mice.
Mohanan D; Gander B; Kündig TM; Johansen P
Eur J Pharm Biopharm; 2012 Feb; 80(2):274-81. PubMed ID: 22024408
[TBL] [Abstract][Full Text] [Related]
16. Immune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model of melanoma.
Goforth R; Salem AK; Zhu X; Miles S; Zhang XQ; Lee JH; Sandler AD
Cancer Immunol Immunother; 2009 Apr; 58(4):517-30. PubMed ID: 18719913
[TBL] [Abstract][Full Text] [Related]
17. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation.
Burgdorf S; Kautz A; Böhnert V; Knolle PA; Kurts C
Science; 2007 Apr; 316(5824):612-6. PubMed ID: 17463291
[TBL] [Abstract][Full Text] [Related]
18. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.
Jasani B; Navabi H; Adams M
Vaccine; 2009 May; 27(25-26):3401-4. PubMed ID: 19200817
[TBL] [Abstract][Full Text] [Related]
19. CD11c(high )dendritic cells are essential for activation of CD4+ T cells and generation of specific antibodies following mucosal immunization.
Fahlén-Yrlid L; Gustafsson T; Westlund J; Holmberg A; Strömbeck A; Blomquist M; MacPherson GG; Holmgren J; Yrlid U
J Immunol; 2009 Oct; 183(8):5032-41. PubMed ID: 19786541
[TBL] [Abstract][Full Text] [Related]
20. Encapsulation of proteins and peptides into biodegradable poly(D,L-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells.
Waeckerle-Men Y; Allmen EU; Gander B; Scandella E; Schlosser E; Schmidtke G; Merkle HP; Groettrup M
Vaccine; 2006 Mar; 24(11):1847-57. PubMed ID: 16288821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
